AkVida GmbH (batch control and batch release; bulk manufacturing, primary and secondary packaging, batch control)

Ukraine

All drugs from this manufacturer

  • IRINOTECAN AMAKSA

    The drug is used to treat advanced colorectal cancer. It may be used either alone or in combination with other drugs (e.g., 5-fluorouracil, folinic acid, cetuximab, bevacizumab, or capecitabine) depending on the stage of the disease and previous treatment.

    Dosage form: concentrate for infusion solution

    Active substance Dosage
    irinotecan 17.33 mg/ml

    ATC: L01CE02